← FDA DRUG APPROVALS

FDA ANDA · ANDA040445

METAXALONE

Sponsor: SANDOZ

APPLICATION
ANDA040445
TYPE
ANDA
ORIGINAL APPROVAL
2010-03-31
LATEST ACTION
2024-11-14
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

METAXALONEPrescription
METAXALONE 800MG · TABLET · ORAL

Approval history

2024-11-14Labeling · Supplement 13 · standardAP
2023-04-25Labeling · Supplement 9 · standardAP
2013-01-10Manufacturing (CMC) · Supplement 3ReviewAP
2010-03-31OriginalLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →